Clinical forecasting is now leveraging innovative informatics capabilities for more precise recruitment and endpoint projections during a study’s crucial…


Bristol-Myers' Opdivo front-and-center in yet another cancer-fighting team-up, this time with Janssen

Bristol-Myers to combo Opdivo, Yervoy with AbbVie's Rova-T in next-gen cancer cocktail trials

Amgen's Humira biosim 'highly similar' to AbbVie original, FDA staffers say

Newest Imbruvica 'breakthrough' tag gives J&J, AbbVie hope for expansion outside blood cancers

Big Pharma harvests far more from transplants than homegrown meds

SCOTUS backs biopharma's most-hated patent challenges

PBM hardball, specialty med slowdown to curb 2017 healthcare spending jump

AbbVie North Chicago plant has second fire

EU official leans on EMA to release AbbVie data on Humira

With May pharma TV ad spending, AbbVie’s Humira tops last year’s total; Pfizer’s Lyrica close behind